Osteoporosis in women with disabilities

Journal of Women's Health

Volumn 13, Issue 4, 2004, Pages 431-437

  Schrager, Sarina ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BODY MASS; COGNITIVE DEFECT; CONTROLLED CLINICAL TRIAL; DISABLED PERSON; FEMALE; FRACTURE; HUMAN; MENTAL DEFICIENCY; PATHOPHYSIOLOGY; POSTMENOPAUSE OSTEOPOROSIS; PRIMARY HEALTH CARE; PRIMARY PREVENTION; REVIEW; RISK FACTOR; STANDARD; STATISTICS; UNITED STATES; WOMEN'S HEALTH;

BODY MASS INDEX; COGNITION DISORDERS; CONTROLLED CLINICAL TRIALS; DISABLED PERSONS; FEMALE; FRACTURES, BONE; HUMANS; MENTAL RETARDATION; OSTEOPOROSIS, POSTMENOPAUSAL; PRIMARY HEALTH CARE; PRIMARY PREVENTION; RISK FACTORS; UNITED STATES; WOMEN'S HEALTH;

EID: 3543061116     PISSN: 15409996     EISSN: None     Source Type: Journal    
DOI: 10.1089/154099904323087123     Document Type: Review

References (43)

1. Thierry JM. Promoting the health and wellness of women with disabilities. J. Wom Health Gender-Based Med 1998;7:505.
2. Hammel J, Nochajski S. Introduction. Aging and developmental disability: Current research, programming, and practice implications. Phys Occup Ther Geriatr 2000;18:1.
3. Lakin KC, Anderson L, Prouty R, Polister B. Community residential services would require expansion of 72% to serve everyone in community settings. Ment Retard 1999;37:251.
4. Lewis MA, Lewis CE, Leake B, King BH, Lindemann R. The quality of health care for adults with developmental disabilities. Public Health Rep 2002;117:174.
5. Shabas D, Weinreb H. Preventive healthcare in women with multiple sclerosis. J Wom Health Gender-Based Med 2000;9:389.
6. Kirk JK, Nichols M, Spanger JG. Use of a peripheral DEXA measurement for osteoporosis screening. Fam Med 2002;34:201.
7. Martin JC, Reid DM. Appendicular measurements in screening women for low axial bone mineral density. Br J Radiol 1996;69:234.
8. Fitzpatrick LA. Secondary causes of osteoporosis. Mayo Clin Proc 2002-77:453.
9. Apkon SD. Osteoporosis in children who have disabilities. Phys Med Rehabil Clin North Am 2002;13:839.
10. Henderson RC, Lark RK, Gurka MJ, et al. Bone density and metabolism in children and adolescents with moderate to severe cerebral palsy. Pediatrics 2002;110 (1 Pt 1):e5.
11. Takata S, Yasui N. Disuse osteoporosis. J Med Invest 2001;48:147.
12. Ott SM. Osteoporosis in women with spinal cord injuries. Phys Med Rehabil Clin North Am 2001;12:111.
13. Garland DE, Adkins RH, Stewart CA, Ashford R, Vigil D. Regional osteoporosis in women who have a complete spinal cord injury. J Bone Joint Surg 2001;83-A:1195.
14. Demirel G, Yilmaz H, Paker N, et al. Osteoporosis after spinal cord injury. Spinal Cord 1998;36:822.
15. Nieves JW, Cosman F, Herbert J, Shen V, Lindsay R. High prevalence of vitamin D deficiency and reduced bone mass in multiple sclerosis. Neurology 1994;44:1687.
16. Cosman F, Nieves J, Komar L, et al. Fracture history and bone loss in patients with MS. Neurology 1998;51:1161.
17. Schwid SR, Goodman AD, Puzas JE, et al. Sporadic corticosteroid pulses and osteoporosis in multiple sclerosis. Arch Neurol 1996;53:753.
18. Sewell K, Schein JR. Osteoporosis therapies for rheumatoid arthritis patients: Minimizing gastrointestinal side effects. Semin Arthritis Rheum 2001;30:288.
19. Suzuki Y, Mizushima Y. Osteoporosis in rheumatoid arthritis. Osteoporosis Int 1997;7(Suppl 3):S217.
20. Laan RF, van Riel PL, van de Putte LB. Bone mass in patients with rheumatoid arthritis. Ann Rheum Dis 1992;51:826.
21. Ray JG, Papaioannou A, Ioannidis G, Adachi JD. Anticonvulsant drug use and low bone mass in adults with neurodevelopmental disorders. Q J Med 2002;95:219.
22. Sato Y, Kondo I, Ishida S, et al. Decreased bone mass and increased bone turnover with valproate therapy in adults with epilepsy. Neurology 2001;57:445.
23. Sheth RD, Wesolowski CA, Jacob JC, et al. Effect of carbamazapine valproate on bone density. J Pediatr 1995;127:256.
24. Feldcamp J. Long-term anticonvulsant therapy leads to low bone mineral density-Evidence for direct drug effects of phenytoin and carbamazepine on human osteoblast-like cells. Exp Clin Endocrinol Diabetes 2000;108:37.
25. Farhat G, Yarmout B, Mikati MA, et al. Effect of antiepileptic drugs on bone density in ambulatory patients. Neurology 2002;58:1348.
26. Lohiya GS, Crinella FM, Tan-Figueroa L, Caires S, Lohiya S. Fracture epidemiology and control in a developmental center. West J Med 1999;170:203.
27. Angelopoulou N, Souftas V, Sakadamis A, Mandroukas K. Bone mineral density in adults with Down's syndrome. Eur Radiol 1999;9:648.
28. Kao C, Chen CC, Wang SJ, Yeh SH. Bone mineral density in children with Down's syndrome detected by dual photon absorptiometry. Nuclear Med Commun 1992;13:773.
29. Sepulveda S, Allison DB, Gomez JE, et al. Low spinal and pelvic bone mineral density among individuals with Down syndrome. Am J Ment Retard 1995;100:109.
30. Aspray TJ, Francis RM, Thompson A, Quilliam SJ, Rawlings DJ, Tyrer SP. Comparison of ultrasound measurements at the heel between adults with mental retardation and control subjects. Bone 1998;22:665.
31. Ryder KM. Appendicular fractures: A significant problem among institutionalized adults with developmental disabilities. Am J Ment Retard 2003;108:340.
32. Jaffe JD, Timell AM, Gulanski BI. Prevalence of low bone density in women with developmental disabilities. J Clin Densitometry 2001;4:25.
33. Center J, Beange H, McElduff A. Osteoporosis in groups with intellectual disability. Aust NZJ Dev Disabilities 1994;19:251.
34. Center J, Beange H, McElduff A. People with mental retardation have an increased prevalence of osteoporosis: A population study. Am J Ment Retard 1998;103:19.
35. Tyler CV, Snyder CW, Zyzanski S. Screening for osteoporosis in community-dwelling adults with mental retardation. Ment Retard 2000;38:316.
36. Mogul H. Preventing fractures among people with developmental disabilities. West J Med 1999;171:77.
37. Nosek MA. Primary care issues for women with severe physical disabilities. J Wom Health Gender-Based Med 1992;1:245.
38. Nelson HD, Helfand M, Woolf SH, Allan JD. Screening for postmenopausal osteoporosis: A review of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 2002;137:529.
39. Bates DW, Black DM, Cummings SR. Clinical use of bone densitometry: Clinical applications. JAMA 2002;288:1898.
40. Adachi JD, Saag KG, Delmas PD, et al. Two-year effects of alendronate on bone mineral density and vertebral fracture in patients receiving glucocorticoids: A randomized, double-blind, placebo-controlled extension trial. Arthritis Rheum 2001;44:202.
41. Doggrell SA. Zoledronate once-yearly increases bone mineral density-Implications for osteoporosis. Expert Opin Pharmacother 2002;3:1007.
42. Hsieh K, Heller T, Miller AB. Risk factors for injuries and falls among adults with developmental disabilities. J Intellectual Disability Res 2001;45:76.
43. Bruckner J, Herge EA. Assessing the risk of falls in elders with mental retardation and developmental disabilities. Top Geriatr Rehabil 2003;19:206.